A global manufacturer of large-scale anticoccidial drugs and traditional Chinese veterinary medicines.

Guangdong Kerun Biopharmaceutical Co., Ltd. was established in 2009 and is a national high-tech enterprise integrating bioengineering, pharmaceutical manufacturing, ecological cultivation and animal husbandry, as well as nutritional research and technological collaboration. The company has successfully passed audits and inspections by authoritative agencies including China’s Ministry of Agriculture and Rural Affairs, Australia’s APVMA, and regulatory bodies in Europe and the United States, and has been awarded designations such as “Guangdong Provincial Postdoctoral Workstation,” “Guangdong Provincial Science and Technology Expert Workstation,” “Guangdong Provincial Engineering Technology Research Center for Traditional Chinese Veterinary Medicinal Preparations,” “Guangdong Provincial Specialized, Refined, Distinctive, and Innovative SME,” “Guangdong Provincial Science and Technology‑Based SME,” and “Guangdong Provincial Innovative SME.”

A global manufacturer of large-scale anticoccidial drugs and traditional Chinese veterinary medicines.

Guangdong Kerun Biopharmaceutical Co., Ltd. was established in 2009 and is a national high-tech enterprise integrating bioengineering, pharmaceutical manufacturing, ecological cultivation and animal husbandry, as well as nutritional research and technological collaboration. The company has successfully passed audits and inspections by authoritative agencies including China’s Ministry of Agriculture and Rural Affairs, Australia’s APVMA, and regulatory bodies in Europe and the United States, and has been awarded designations such as “Guangdong Provincial Postdoctoral Workstation,” “Guangdong Provincial Science and Technology Expert Workstation,” “Guangdong Provincial Engineering Technology Research Center for Traditional Chinese Veterinary Medicinal Preparations,” “Guangdong Provincial Specialized, Refined, Distinctive, and Innovative SME,” “Guangdong Provincial Science and Technology‑Based SME,” and “Guangdong Provincial Innovative SME.”

Leaders of Anyou Group paid a visit to our company for inspection and guidance.

2017-08-16


On August 14–15, Duan Shaojun, Vice President of Anyou Biotechnology Group Co., Ltd., along with his delegation, visited our company’s new plant, accompanied by General Manager Zeng and Technical Director Qian of Guangdong Kerun Biopharmaceutical Co., Ltd.

The visiting delegation gathered in our company’s second-floor conference room to hear a briefing on the progress of the new plant’s construction. First, our General Manager, Zeng Meiju, extended a warm welcome to President Duan Shaojun and his delegation for their visit and inspection. Following this, an administrative specialist from the company provided a detailed overview of the new plant’s development.

 

   

 

Following the presentation, the visiting delegation conducted an on-site inspection, touring our company’s Quality Control Center, the powder and granular formulation production lines, the premix production line, the pelleted premix production line, the feed production line, the traditional Chinese medicine extraction line, and the warehouse. They gained a thorough understanding of the laboratory’s instrumentation and the workshop’s automated, enclosed production equipment.

During the tour, the visiting delegation repeatedly inquired about certain production equipment and sought to understand its manufacturing processes, expressing their intention to learn from and adapt these practices to continuously enhance production efficiency and elevate process standards.


 

The visiting delegation toured our company’s dormitory buildings, cafeteria, and employee recreation facilities, praising our garden‑like office and living environments.

This visit provided us with an opportunity to exchange ideas and learn; at the same time, our customers’ praise is the highest recognition of our company. Through mutual understanding and open dialogue, we continue to explore new technologies and processes, draw on best practices, and make ongoing improvements—working together in win‑win collaboration to pursue shared growth.

%E7%AC%AC%E4%B8%80%EF%BC%8C%E6%9C%80%EF%BC%8C%E4%BC%98%E7%A7%80%EF%BC%8C%E5%A2%9E%E5%BC%BA%EF%BC%8C%E4%B8%80%E6%B5%81%EF%BC%8C%E5%8D%93%E8%B6%8A%EF%BC%8C%E9%A2%86%E5%85%88%EF%BC%8C%E5%85%88%E8%BF%9B%EF%BC%8C%E5%BC%95%E9%A2%86

Sorry,当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry,The current column has no content!

You can view other columns or return Home